EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis

Ganimete Bajraktari, Tanja Elger, Muriel Huss, Johanna Loibl, Andreas Albert, Arne Kandulski iD, Martina Müller iD, Hauke Christian Tews, Christa Buechler iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ganimete Bajraktari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Biomarkers, Galectin 3, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sclerosing cholangitis (PSC) is a serious liver disease associated with inflammatory bowel disease (IBD). Galectin-3, an inflammatory and fibrotic molecule, has elevated circulating levels in patients with chronic liver disease and inflammatory bowel disease (IBD). This study aims to clarify whether galectin-3 can differentiate between patients with IBD, PSC, and PSC-IBD. Our study measured serum galectin-3 levels in 38 healthy controls, 55 patients with IBD, and 22 patients with PSC (11 patients had underlying IBD and 11 patients did not), alongside the urinary galectin-3 of these patients and 18 controls. Serum and urinary galectin-3 levels in IBD patients were comparable to those in controls. Among IBD patients, those with high fecal calprotectin, indicating severe disease, exhibited lower serum and elevated urinary galectin-3 levels compared to those with low calprotectin levels. Serum galectin-3 levels were inversely correlated with C-reactive protein levels. PSC patients displayed higher serum and urinary galectin-3 levels than IBD patients, with the highest serum levels observed in PSC patients with coexisting IBD. There was no correlation between serum and urinary galectin-3 levels and laboratory indicators of liver injury in both IBD and PSC patients. In conclusion, this study demonstrates that serum and urinary galectin-3 levels can distinguish IBD from PSC patients, and also reveals higher serum galectin-3 levels in PSC-IBD patients compared to those with isolated PSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingBiomarkersGalectin 3Inflammatory Bowel DiseasesHumansFemaleMaleMiddle AgedAdultLeukocyte L1 Antigen ComplexC-Reactive ProteinCase-Control StudiesAgedGalectinsBlood Proteins

Stichwörter der Autor:innen

aminotransferasecalprotectingalectin-3inflammatory bowel diseaseprimary sclerosing cholangitisurine

Substanzen

BiomarkersGalectin 3Leukocyte L1 Antigen ComplexLGALS3 protein, humanC-Reactive ProteinGalectinsBlood Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.

ORCID-Profile: Arne Kandulski, Martina Müller, Christa Buechler

Zitieren

APA

Bajraktari, G., Elger, T., Huss, M., Loibl, J., Albert, A., Kandulski, A., Müller, M., Tews, H. C., & Buechler, C. (2024). Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094765

Vancouver

Bajraktari G, Elger T, Huss M, Loibl J, Albert A, Kandulski A, et al. Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094765

BibTeX
@article{Bajraktari2024,
  author = {Bajraktari, Ganimete and Elger, Tanja and Huss, Muriel and Loibl, Johanna and Albert, Andreas and Kandulski, Arne and Müller, Martina and Tews, Hauke Christian and Buechler, Christa},
  title = {Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094765}
}
Kostenlos starten →